Alirocumab significantly reduces high-risk coronary plaques Presented ByProf. Lorenz Räber, Bern University Hospital, Switzerland TrialPhase 3, PACMAN-AMI ConferenceACC 2022 15 June, 2022 15:20
ACC 2022 Highlights Podcast Presented ByDr Rachel Giles JournalMedicom ConferenceACC 2022 20 April, 2022 10:50